Simpler Grants.gov #HT942526ALSRPTIA

Army ALS Research Program Therapeutic Idea Award Grant Opportunity

The Dept. of the Army is inviting applications for the ALS Research Program Therapeutic Idea Award, focusing on innovative research for ALS drug or therapy discovery. - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA), under the Congressionally Directed Medical Research Programs (CDMRP) - Products/Services Requested: - ALS Therapeutic Idea Research Grant - Up to 12 awards available - Each award capped at $840,000 - Total funding pool: $10,080,000 - Maximum period of performance: two years per award - Funding supports hypothesis-driven, high-risk, high-gain research to generate preliminary data for future ALS therapeutic development - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant opportunity - Unique or Notable Requirements: - Open to both extramural and intramural organizations with unrestricted eligibility - Applicants must have active registrations with SAM.gov, eBRAP.org, and Grants.gov - Emphasis on impact, innovation, and hypothesis-driven research proposals - Place of Performance: - US Army Medical Research Acquisition Activity (USAMRAA)

Description

The fiscal year 2026 Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award supports new, innovative, high-risk, high-gain ideas aimed at ALS drug or therapy discovery. The award funds hypothesis-driven studies expected to generate preliminary data for future therapeutic investigation. Potential impact and innovation are key features, and applications may achieve interpretable results without preliminary data. The program expects to fund approximately 12 awards with a total funding amount of $10,080,000.

View original listing